Previous 10 | Next 10 |
Search all articles related articles and news articles from the OTCMKTS NASDAQ and NYSE markets.
Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of The Wendy's Co (NASDAQ: WEN) with a p...
Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of The Wendy's Co (NASDAQ: WEN) with a p...
Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of The Wendy's Co (NASDAQ: WEN) with a p...
President Joe Biden is currently hosting South Korean President Yoon Suk Yeol and Japanese Prime Minister Fumio Kishida at Camp David. While there&...
Roots Analysis has done a detailed study on “Global Cell Cytometry Market: Focus on High Throughput Flow Cytometry and Image Cytometry, 2022-2035”.
The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics.
LQR House (NasdaqGM: LQR) stock's weakness following its milestone IPO presents a value investment proposition worth considering. The stock initially surged over 40%
LQR House (NasdaqGM: LQR) scored a major milestone last week, securing a listing on the NasdaqGM. While shares have zig-zagged since, the over 40% surge...
LQR House (NasdaqGM: LQR) shares soared by 40% after making their NasdaqGM debut. The rally led to LQR shares reaching $7.01 before giving back gains in the afternoon session.
Non-viral vectors have emerged as an effective and safe delivery vehicle for genetically-modified therapies; the growing interest in these vectors has further resulted in an adjacent demand for versatile transfection reagents and systems.
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-3.60%Change Percent:
Exicure Inc. Company Name:
XCUR Stock Symbol:
OTCMKTS Market:
exicuretx.com Website: